United Health Products Inc. Supplies Initial Stocking Order to AMD-Ritmed

HENDERSON, NV--(Marketwired - Oct 10, 2014) - United Health Products Inc. (OTCQB: UEEC) announced that its Distributor AMD-Ritmed has placed initial sampling and stocking orders. AMD-Ritmed has engaged its entire marketing and distribution network throughout the US and Canada. AMD is planning to showcase HemoStyp® at various events and various industry tradeshows. The Pricing, Data Analysis and Coding (PDAC) Contractor has reviewed the Hemostyp® Product Line and has approved the products for billing via the Healthcare Common Procedure Coding System (HCPCS) through the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) system. This approval was granted to United Health Products and now allows users to be reimbursed through the DME MAC system.

About United Health Products Inc.
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

About AMD-Ritmed
For over 30 years, AMD-Ritmed has been a leading manufacturer of surgical dressings and related products as well as distributor of products utilized in hospitals and healthcare facilities. AMD-Ritmed has evolved into a multinational manufacturer and distributor of wound care, personal protection, and general medical and surgical supplies. For more on AMD-Ritmed visit: www.amdritmed.com

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.